Listed

Relmada Therapeutics, Inc.

RLMDNasdaqCIK 1553643HealthcareFiscal year ends Dec 31

Reports and events: 239 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Relmada Therapeutics, Inc., Reports and events
FiledFormWhat it isAccession number
2018-09-2817:19 ET10-KAnnual reportPeriod 2018-06-300001213900-18-013238
2018-08-1716:30 ET8-K4.01 Change of auditor; 9.01 Financial statements and exhibits0001213900-18-011356
2018-05-1416:32 ET10-QQuarterly reportPeriod 2018-03-310001213900-18-006121
2018-04-0508:30 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001213900-18-004081
2018-04-0216:33 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors0001213900-18-003881
2018-02-1216:32 ET10-QQuarterly reportPeriod 2017-12-310001213900-18-001597
2018-02-0516:59 ET8-K5.07 Shareholder vote results0001213900-18-001309
2018-01-1916:38 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001213900-18-000707
2017-12-1516:38 ETDEF 14AProxy statementPeriod 2017-12-180001213900-17-013299
2017-11-1417:11 ET10-QQuarterly reportPeriod 2017-09-300001213900-17-012121
2017-10-0416:50 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity0001213900-17-010300
2017-09-2816:42 ET10-KAnnual reportPeriod 2017-06-300001213900-17-010097
2017-06-1516:30 ET8-K1.01 Entry into a material agreement0001213900-17-006520
2017-06-0816:42 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors0001213900-17-006258
2017-05-1808:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001213900-17-005449
2017-05-1514:02 ET10-QQuarterly reportPeriod 2017-03-310001213900-17-005185
2017-04-2716:30 ET8-K5.02 Departure or appointment of officers or directors0001213900-17-004315
2017-02-1716:57 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001213900-17-001560
2017-02-1016:17 ET10-QQuarterly reportPeriod 2016-12-310001213900-17-001191
2017-02-0117:00 ET8-K5.07 Shareholder vote results0001213900-17-000853
2016-12-3016:17 ETDEF 14AProxy statementPeriod 2016-01-270001213900-16-019804
2016-11-1016:46 ET10-QQuarterly reportPeriod 2016-09-300001213900-16-018211
2016-09-1207:30 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001213900-16-016676
2016-09-0917:13 ET10-KAnnual reportPeriod 2016-06-300001213900-16-016664
2016-06-1716:51 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001213900-16-014330
2016-06-0208:30 ETSC 13D/AOwnership report, active investor, amended0001144204-16-106396
2016-05-1316:25 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001213900-16-013287
2016-05-0917:13 ET10-QQuarterly reportPeriod 2016-03-310001213900-16-013088
2016-02-0516:47 ET10-QQuarterly reportPeriod 2015-12-310001213900-16-010641
2016-01-1308:39 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001213900-16-010071
2015-12-3116:15 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001213900-15-009862
2015-12-3012:42 ET8-K5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits0001213900-15-009790
2015-12-2917:05 ETSC 13D/AOwnership report, active investor, amended0001144204-15-073168
2015-12-2308:48 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001213900-15-009675
2015-12-2117:22 ETSC 13D/AOwnership report, active investor, amended0001144204-15-071997
2015-12-1408:51 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001213900-15-009450
2015-12-1109:29 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001213900-15-009423
2015-12-1008:14 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001213900-15-009388
2015-12-0917:26 ETSC 13D/AOwnership report, active investor, amended0001144204-15-070173
2015-12-0916:31 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001213900-15-009378
2015-12-0910:31 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001213900-15-009368
2015-12-0815:23 ETSC 13D/AOwnership report, active investor, amended0001144204-15-069845
2015-12-0721:56 ETSC 13D/AOwnership report, active investor, amended0001144204-15-069493
2015-11-2716:03 ETDEF 14AProxy statementPeriod 2015-12-300001213900-15-009137
2015-11-2516:00 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001213900-15-009111
2015-11-1216:41 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001213900-15-008498
2015-11-0616:50 ET10-QQuarterly reportPeriod 2015-09-300001213900-15-008265
2015-11-0517:22 ETSC 13D/AOwnership report, active investor, amended0001144204-15-063147
2015-11-0508:05 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001213900-15-008191
2015-10-2217:43 ETSC 13DOwnership report, active investor0001144204-15-060273

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 15:42 ET. Listed shows no prices and gives no investment advice.